# Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

> **NCT02614521** · — · WITHDRAWN · sponsor: **Elpen Pharmaceutical Co. Inc.**

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** pulmonary veins ablation's successful outcome

## Key facts

- **NCT ID:** NCT02614521
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02614521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02614521, "Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02614521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*